Our analysis suggests that PGRMC1 seems a novel oncogene for HNSC since its correlation with signature genes of tumor proliferation, metabolism and tumor metastasis, and its over-expression could be used as an indicator for clinical unfavorable prognosis of HNSC patients and many other cancer types. This evidence concerns the gene PGRMC1 and cancer.